GLP-1-based medications including Ozempic and Wegovy (semaglutide) and Mounjaro (tirzepatide, which also targets GIP receptors) have already been linked to benefits involving blood glucose, weight, heart health, and kidney protection
Journal of Medicinal Chemistry, 57 (22), 9220
Like TRT, sermorelin is only available by prescription
however, while it effectively lowers glycated hemoglobin (HbA1c), it has minimal effects on weight loss and limited durability in glycemic control
3b), albeit that the overall CTR/RAMP1 ECD orientation relative to the core differs between these structures
And we just don't know." The drugs' makers are also following the "Ozempic babies" phenomenon